Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:application |
cancer research
|
| gptkbp:avionics |
WPC-1139
|
| gptkbp:built |
limited funding
|
| gptkbp:campusFacilities |
gptkb:XYZ_University
|
| gptkbp:chemicalFormula |
polar
small molecule reacts with acids requires specialized equipment stable at room temperature handled with care interacts with proteins aryl amides contains pyrimidine ring mass spectrometry used several derivatives synthesized C12H15N3O2 |
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:collaborations |
gptkb:ABC_Pharmaceuticals
international partnerships with industry partners ongoing with multiple institutions |
| gptkbp:compatibleWith |
moderate
|
| gptkbp:competitors |
high
|
| gptkbp:composedOf |
high
multi-step synthesis |
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:drugInterdiction |
under investigation
|
| gptkbp:environmental_impact |
minimal
|
| gptkbp:environmentalImpact |
low
|
| gptkbp:financial_aid |
stable under normal conditions
|
| gptkbp:funding |
grants received
|
| gptkbp:future_plans |
clinical trials planned
|
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-1138
|
| gptkbp:is_aimed_at |
various cancers
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:judgingCriteria |
HPLC_used
|
| gptkbp:market |
not commercially available
|
| gptkbp:notableWork |
potential for new therapies
significant in oncology |
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)-6-methylpyrimidin-2-yl)benzamide
|
| gptkbp:patentAssignee |
gptkb:XYZ_University
|
| gptkbp:patentExpiration |
2030
|
| gptkbp:patentStatus |
patented
|
| gptkbp:publications |
multiple articles published
followed in studies |
| gptkbp:regulatoryCompliance |
not approved for human use
|
| gptkbp:related_to |
gptkb:WPC-1137
|
| gptkbp:releaseYear |
2010
|
| gptkbp:research |
growing interest
varied approaches used |
| gptkbp:research_focus |
antitumor activity
|
| gptkbp:researchAndDevelopment |
promising results observed
|
| gptkbp:safety |
wear gloves
|
| gptkbp:safety_features |
not fully established
|
| gptkbp:safetyFeatures |
available
established protocols followed |
| gptkbp:scientificName |
conducted
|
| gptkbp:storage |
cool, dry place
|
| gptkbp:targets |
kinase inhibitors
specific receptors |
| gptkbp:triggerType |
inhibits specific enzymes
|
| gptkbp:uses |
research chemical
|
| gptkbp:weight |
233.27 g/mol
|